FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants. / Lauritzen, Lotte; Amundsen, Ingvild D; Damsgaard, Camilla Trab; Lind, Mads Vendelbo; Schnurr, Theresia Maria; Hansen, Torben; Michaelsen, Kim F.; Vogel, Ulla.

I: Journal of Nutrition, Bind 149, Nr. 5, 2019, s. 708-715.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Lauritzen, L, Amundsen, ID, Damsgaard, CT, Lind, MV, Schnurr, TM, Hansen, T, Michaelsen, KF & Vogel, U 2019, 'FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants', Journal of Nutrition, bind 149, nr. 5, s. 708-715. https://doi.org/10.1093/jn/nxy323

APA

Lauritzen, L., Amundsen, I. D., Damsgaard, C. T., Lind, M. V., Schnurr, T. M., Hansen, T., Michaelsen, K. F., & Vogel, U. (2019). FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants. Journal of Nutrition, 149(5), 708-715. https://doi.org/10.1093/jn/nxy323

Vancouver

Lauritzen L, Amundsen ID, Damsgaard CT, Lind MV, Schnurr TM, Hansen T o.a. FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants. Journal of Nutrition. 2019;149(5):708-715. https://doi.org/10.1093/jn/nxy323

Author

Lauritzen, Lotte ; Amundsen, Ingvild D ; Damsgaard, Camilla Trab ; Lind, Mads Vendelbo ; Schnurr, Theresia Maria ; Hansen, Torben ; Michaelsen, Kim F. ; Vogel, Ulla. / FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants. I: Journal of Nutrition. 2019 ; Bind 149, Nr. 5. s. 708-715.

Bibtex

@article{7db42da67db4443b88082b5ceb8ebe19,
title = "FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants",
abstract = "Background: Dietary intake of polyunsaturated fatty acids (PUFAs), e.g., linoleic acid and n-3 (ω-3) long-chain PUFAs, has been shown in adults to affect plasma cholesterol and triglycerides (TGs), respectively. Little is known about the effects of PUFAs on plasma lipids in early life.Objective: The aim of this study was to explore the associations between plasma concentrations of total, LDL, and HDL cholesterol and TGs in infants and 2 single nucleotide polymorphisms (SNPs) in the fatty acid desaturase genes (FADS) oppositely associated with docosahexaenoic acid (rs1535 and rs174448) and potential effect modification by a functional peroxisome proliferator-activated receptor-γ2 gene variant (PPARG2 Pro12Ala).Methods: In 9-mo-old infants (n = 561) from 3 Danish cohorts, we analyzed associations between plasma lipids, erythrocyte PUFAs, and FADS SNPs, and interactions with PPARG2 Pro12Ala genotype, by multiple linear regression. We also examined potential effect modification by breastfeeding, as 46% of the infants were still being breastfed.Results: Minor allele carriage of rs174448 was associated with lower total cholesterol (difference: -0.22 mmol/L; 95% CI: -0.37, -0.06 mmol/L; P = 0.006) and LDL cholesterol (difference: -0.15 mmol/L; 95% CI: -0.29, -0.01 mmol/L; P = 0.035), but no associations were observed with TGs or for rs1535. Minor allele carriage of both FADS SNPs was associated with 1 SD lower HDL cholesterol, but only in currently breastfed infants (rs174448 × breastfeeding, P = 0.080; rs1535 × breastfeeding, P = 0.030) and PPARG2 minor allele carriers (rs174448 × PPARG2, P = 0.001; rs1535 × PPARG2, P = 0.004). Erythrocyte arachidonic acid and eicosapentaenoic acid were inversely associated with LDL cholesterol [estimated effect (β): -0.3 mmol/L; 95% CI: -0.06, -0.00 mmol/L per percentage of fatty acids (FA%); P = 0.035] and TGs (β: -0.23 mmol/L; 95% CI: -0.41, -0.05 mmol/L per FA%; P = 0.015), respectively.Conclusions: The observed associations with FADS variants indicate that PUFAs are involved in plasma lipid regulation in 9-mo-old infants. Observed FADS SNP differences and interactions with breastfeeding and PPARG2 warrant additional studies to explore the effects of individual FADS SNPs on PUFA status and potential genetic modification of dietary PUFA effects.",
keywords = "Faculty of Science, n–3 polyunsaturated fatty acids, Plasma cholesterol, Plasma triacylglycerol, Fatty acid desaturase, Peroxisome proliferator-activated receptor",
author = "Lotte Lauritzen and Amundsen, {Ingvild D} and Damsgaard, {Camilla Trab} and Lind, {Mads Vendelbo} and Schnurr, {Theresia Maria} and Torben Hansen and Michaelsen, {Kim F.} and Ulla Vogel",
note = "CURIS 2019 NEXS 152 Copyright {\textcopyright} American Society for Nutrition 2019.",
year = "2019",
doi = "10.1093/jn/nxy323",
language = "English",
volume = "149",
pages = "708--715",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "5",

}

RIS

TY - JOUR

T1 - FADS and PPARG2 single nucleotide polymorphisms are associated with plasma lipids in 9-mo-old infants

AU - Lauritzen, Lotte

AU - Amundsen, Ingvild D

AU - Damsgaard, Camilla Trab

AU - Lind, Mads Vendelbo

AU - Schnurr, Theresia Maria

AU - Hansen, Torben

AU - Michaelsen, Kim F.

AU - Vogel, Ulla

N1 - CURIS 2019 NEXS 152 Copyright © American Society for Nutrition 2019.

PY - 2019

Y1 - 2019

N2 - Background: Dietary intake of polyunsaturated fatty acids (PUFAs), e.g., linoleic acid and n-3 (ω-3) long-chain PUFAs, has been shown in adults to affect plasma cholesterol and triglycerides (TGs), respectively. Little is known about the effects of PUFAs on plasma lipids in early life.Objective: The aim of this study was to explore the associations between plasma concentrations of total, LDL, and HDL cholesterol and TGs in infants and 2 single nucleotide polymorphisms (SNPs) in the fatty acid desaturase genes (FADS) oppositely associated with docosahexaenoic acid (rs1535 and rs174448) and potential effect modification by a functional peroxisome proliferator-activated receptor-γ2 gene variant (PPARG2 Pro12Ala).Methods: In 9-mo-old infants (n = 561) from 3 Danish cohorts, we analyzed associations between plasma lipids, erythrocyte PUFAs, and FADS SNPs, and interactions with PPARG2 Pro12Ala genotype, by multiple linear regression. We also examined potential effect modification by breastfeeding, as 46% of the infants were still being breastfed.Results: Minor allele carriage of rs174448 was associated with lower total cholesterol (difference: -0.22 mmol/L; 95% CI: -0.37, -0.06 mmol/L; P = 0.006) and LDL cholesterol (difference: -0.15 mmol/L; 95% CI: -0.29, -0.01 mmol/L; P = 0.035), but no associations were observed with TGs or for rs1535. Minor allele carriage of both FADS SNPs was associated with 1 SD lower HDL cholesterol, but only in currently breastfed infants (rs174448 × breastfeeding, P = 0.080; rs1535 × breastfeeding, P = 0.030) and PPARG2 minor allele carriers (rs174448 × PPARG2, P = 0.001; rs1535 × PPARG2, P = 0.004). Erythrocyte arachidonic acid and eicosapentaenoic acid were inversely associated with LDL cholesterol [estimated effect (β): -0.3 mmol/L; 95% CI: -0.06, -0.00 mmol/L per percentage of fatty acids (FA%); P = 0.035] and TGs (β: -0.23 mmol/L; 95% CI: -0.41, -0.05 mmol/L per FA%; P = 0.015), respectively.Conclusions: The observed associations with FADS variants indicate that PUFAs are involved in plasma lipid regulation in 9-mo-old infants. Observed FADS SNP differences and interactions with breastfeeding and PPARG2 warrant additional studies to explore the effects of individual FADS SNPs on PUFA status and potential genetic modification of dietary PUFA effects.

AB - Background: Dietary intake of polyunsaturated fatty acids (PUFAs), e.g., linoleic acid and n-3 (ω-3) long-chain PUFAs, has been shown in adults to affect plasma cholesterol and triglycerides (TGs), respectively. Little is known about the effects of PUFAs on plasma lipids in early life.Objective: The aim of this study was to explore the associations between plasma concentrations of total, LDL, and HDL cholesterol and TGs in infants and 2 single nucleotide polymorphisms (SNPs) in the fatty acid desaturase genes (FADS) oppositely associated with docosahexaenoic acid (rs1535 and rs174448) and potential effect modification by a functional peroxisome proliferator-activated receptor-γ2 gene variant (PPARG2 Pro12Ala).Methods: In 9-mo-old infants (n = 561) from 3 Danish cohorts, we analyzed associations between plasma lipids, erythrocyte PUFAs, and FADS SNPs, and interactions with PPARG2 Pro12Ala genotype, by multiple linear regression. We also examined potential effect modification by breastfeeding, as 46% of the infants were still being breastfed.Results: Minor allele carriage of rs174448 was associated with lower total cholesterol (difference: -0.22 mmol/L; 95% CI: -0.37, -0.06 mmol/L; P = 0.006) and LDL cholesterol (difference: -0.15 mmol/L; 95% CI: -0.29, -0.01 mmol/L; P = 0.035), but no associations were observed with TGs or for rs1535. Minor allele carriage of both FADS SNPs was associated with 1 SD lower HDL cholesterol, but only in currently breastfed infants (rs174448 × breastfeeding, P = 0.080; rs1535 × breastfeeding, P = 0.030) and PPARG2 minor allele carriers (rs174448 × PPARG2, P = 0.001; rs1535 × PPARG2, P = 0.004). Erythrocyte arachidonic acid and eicosapentaenoic acid were inversely associated with LDL cholesterol [estimated effect (β): -0.3 mmol/L; 95% CI: -0.06, -0.00 mmol/L per percentage of fatty acids (FA%); P = 0.035] and TGs (β: -0.23 mmol/L; 95% CI: -0.41, -0.05 mmol/L per FA%; P = 0.015), respectively.Conclusions: The observed associations with FADS variants indicate that PUFAs are involved in plasma lipid regulation in 9-mo-old infants. Observed FADS SNP differences and interactions with breastfeeding and PPARG2 warrant additional studies to explore the effects of individual FADS SNPs on PUFA status and potential genetic modification of dietary PUFA effects.

KW - Faculty of Science

KW - n–3 polyunsaturated fatty acids

KW - Plasma cholesterol

KW - Plasma triacylglycerol

KW - Fatty acid desaturase

KW - Peroxisome proliferator-activated receptor

U2 - 10.1093/jn/nxy323

DO - 10.1093/jn/nxy323

M3 - Journal article

C2 - 31050749

VL - 149

SP - 708

EP - 715

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 5

ER -

ID: 217549684